Concepedia

Heng Du

HD

36

Publications

1.2K

Citations

22

H-Index

2011

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Sichuan University

West China Hospital of Sichuan University

Dana-Farber Cancer Institute

Heng Du is an author at Brigham and Women's Hospital specializing in medicine, tumor biology, and cancer research.

ORCID

Top concepts

Publications per year

2011–2024

36

Publications

36

<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors

Andrew J. Wagner, Vinod Ravi, Richard F. Riedel et al. · Journal of Clinical Oncology · 2021 · 155 citations · Full text

mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion

Heng-Jia Liu, Heng Du, Damir Khabibullin et al. · Nature Communications · 2023 · 103 citations · Full text

Mammalian SWI/SNF Complex Genomic Alterations and Immune Checkpoint Blockade in Solid Tumors

Sarah Abou Alaiwi, Amin H. Nassar, Wanling Xie et al. · Cancer Immunology Research · 2020 · 77 citations · Full text

TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy

Heng-Jia Liu, Patrick H. Lizotte, Heng Du et al. · JCI Insight · 2018 · 73 citations · Full text

, , +21

Genetic alterations and epigenetic alterations of cancer-associated fibroblasts

Heng Du, Guowei Che · Oncology Letters · 2016 · 54 citations · Full text

, , +14

Rows per page

1–5 of 36